Patents Represented by Attorney Roche Diagnostics Operations, Inc.
  • Patent number: 6835351
    Abstract: An optical-chemical sensor which is suitable for the continuous and discontinuous determination by luminescence optics of the concentration of chloride in an aqueous sample and which comprises a luminescence indicator (I) and a polymer (H) carrying the luminescence indicator (I) is characterized in that the luminescence indicator (I) is a non-lipophile acridine or bisacridine compound and the polymer (H) is a linear-chain hydrophile polymer soluble in an organic solvent, whereby it is possible to excite the sensor by commercially available LEDs, to manufacture very large numbers thereof at a moderate cost and in a reproducible way and, preferably, to use it for the determination of physiological chloride concentrations and the sensor furthermore has a wide dynamic measuring range for the determination of chloride; a high sensitivity, stability and reproducibility; a high selectivity for chloride; and a low pH cross-sensitivity.
    Type: Grant
    Filed: January 2, 2003
    Date of Patent: December 28, 2004
    Assignee: F. Hoffmann-La Roche AG
    Inventors: Christian Huber, Tobias Werner, Otto S. Wolfbeis, Douglas E. Bell, Susannah Young
  • Patent number: 6821744
    Abstract: A method for quantifying an HIV protease inhibitor in a sample includes combining HIV protease, a conjugate comprising an HIV protease inhibitor analog, and a sample suspected of containing an HIV protease inhibitor. The HIV protease and the conjugate are capable of forming a detectable complex. The method also includes measuring the amount of the detectable complex, and relating the amount of the detectable complex to a concentration of the HIV protease inhibitor in the sample.
    Type: Grant
    Filed: October 29, 2002
    Date of Patent: November 23, 2004
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Herbert von der Eltz, Lili Arabshahi, Haijuan Li, Erasmus Huber
  • Patent number: 6811998
    Abstract: The present invention provides a method for the measurement of an analyte in biological samples whereby an uncompetitive inhibitor is coupled to a ligand and utilized in a homogeneous assay. The analyte can be a drug or drug derivative, hormone, polypeptide, or oligonucleotide. The present invention also provides novel compounds, assay reagents and packaged kits useful for performing such measurements.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: November 2, 2004
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Mitali Ghoshal, Gerald Sigler, Raymond A. Hui, Ronald Hawley, Eva Hoess, Erasmus J. Huber, John W. Patterson, Salvatore J. Salamone, Allan Dorn
  • Patent number: 6812019
    Abstract: Process for the production of a protein with citrate lyase activity by expressing a suitable plasmid in a host organism and isolating the protein in an active form, wherein the plasmid contains the information from a gene cluster composed of at least six genes and an inducible promoter. Furthermore the invention concerns the use of the recombinant enzyme and a corresponding test kit for the determination of citric acid.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: November 2, 2004
    Assignee: Roche Diagnostics GmbH
    Inventors: Michael Bott, Peter Dimroth, Karin Schneider
  • Patent number: 6808619
    Abstract: In an electrode system, particularly for electrochemical sensors, which comprises a working electrode, a counterelectrode and an electrolyte, the counterelectrode is constituted by a material containing an elementary carbon, whereby the long-term stability of the electrode system is considerably increased (FIG. 2).
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: October 26, 2004
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Helmut Offenbacher
  • Patent number: 6794496
    Abstract: The present invention provides hapten derivatives useful for the preparation of antigens, antibodies and reagents for use in immunoassays for the detection of LSD and 2-oxo-3-hydroxy LSD. In the present invention, the 2-oxy LSD nucleus is derivatized out of the indole nitrogen to form an aminoalkyl derivative. The resulting haptens can then be further modified at this functionalized position for linking to appropriate immunogenic or labeling groups to provide reagents for immunoassays having substantially equal specificity for both LSD and 2-oxo-3-hydroxy-LSD.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: September 21, 2004
    Assignee: Roche Diagnostics Corporation
    Inventors: Mitali Ghoshal, Stephen Vitone, Gerald F. Sigler, Alan J. McNally
  • Patent number: 6780064
    Abstract: The invention concerns an analytical system in which at least two modules are in contact with one another by a connecting plug, and a connecting plug which is suitable for connecting modules. When two modules are connected by the connecting plug a part of the plug extends partially underneath the bottoms of the modules such that the plug connection is secured by the dead weight of the modules.
    Type: Grant
    Filed: July 9, 2002
    Date of Patent: August 24, 2004
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Guido Abel, Friedrich Ackermann, Manfred Augstein, Wolfgang Fabian
  • Patent number: 6777246
    Abstract: A reagent for use in immunoassays reduces interference in particle agglutination assays. The reagent contains particles having covalently bound antibodies and a tertiary amine compound of formula (I): N(R1—X)(R2—Y)(R3—Z)  (I). The moieties R1, R2, and R3 are independently alkyl or alkyl ether. The moieties X, Y, and Z are independently —OH, —O—R4, —S—R4, —C(═O)—OH, —C(═O)—OR4, or —C(═O)—NHR4 (R4 is alkyl).
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: August 17, 2004
    Assignee: Roche Diagnostics GmbH
    Inventors: Christopher C. Lawrence, Armen B. Shanafelt